17
Participants
Start Date
June 10, 2004
Primary Completion Date
June 15, 2011
Study Completion Date
June 15, 2011
Agalsidase alfa
0.2 mg/kg agalsidase alfa administered by IV infusion over 40 (+/- 10) minutes every other week for 52 weeks, with periodic reassessments for study continuation beyond 52 weeks
NYU School of Medicine, New York
Sacred Heart Hospital, Allentown
Clinical Center, National Institutes of Health, Bethesda
Memorial Hospital, Easton
Office of Michael Cohen, Stafford
Children's Physician Group, Palm Beach Gardens
East Tennessee Children's Hospital, Knoxville
University of Tennessee, Health Science Center, Memphis
St. Louis Children's Hospital, St Louis
Christus St. Patrick Hospital, Lake Charles
Institute of Metabolic Diseases, Dallas
Tucson Access Center of Arizona Kidney Disease Hypertension Center, Tucson
University of Arizona Health Sciences Center, Tucson
The Hospital for Sick Children, Toronto
Lead Sponsor
Shire
INDUSTRY